FDA Approves Pfizer Booster For Kids Ages 12-15

CNBC reports:

The Food and Drug Administration on Monday expanded eligibility for Pfizer and BioNTech booster shots to children ages 12 to 15 years old, as school restarts after winter break amid a surge of Covid infections across the U.S.

The FDA also shortened the time between primary vaccination and the booster dose to at least five months, down from six months. The agency also authorized a third vaccine dose as part of the primary series of shots for children ages 5 through 11 who have compromised immune systems.

“The recent rise in COVID-19 cases is concerning to all and today’s decision by the FDA to further expand the Emergency Use Authorization of a booster dose of our vaccine is critical to help us ultimately defeat this pandemic,” Pfizer CEO Albert Bourla said in a statement.

Read the full article.

The FDA expanded eligibility for Pfizer and BioNTech booster shots to children ages 12 to 15 years old

The CDC still has to sign off an expanded eligibility for 12- to 15-year-old kidshttps://t.co/l26GusToTz

— Sheba Turk (@ShebaTurk) January 3, 2022